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Gestational diabetes mellitus (GDM) is a primary concern in India affecting approximately 
five million women each year. Existing literature indicate that prediabetes and diabetes 
affect approximately six million births in India alone, of which 90% are due to GDM. 
Studies reveal that there is no consensus among physicians and health-care providers 
in India regarding management of GDM prepartum and postpartum despite available 
guidelines. Also, there is no consensus among physicians as to when a woman should 
undergo oral glucose tolerance test after delivery. This clearly shows that management 
of GDM is challenging and controversial in India due to conflicting guidelines and 
treatment protocols, despite availability of straightforward protocols for screening and 
management. Also, a collaborative approach remains a key for GDM management, as 
patient compliance and proper educational interventions promote better pregnancy 
outcomes. Management of GDM plays a pivotal role, as women with GDM have an 
increased chance of developing diabetes mellitus 5–10  years after pregnancy. Also, 
children born in GDM pregnancies face an increased risk for obesity and type 2 diabetes. 
The cornerstone for the management of GDM is glycemic control and quality nutritional 
intake. GDM management is complex in India, and existing challenges are multifactorial. 
However, there are little published data outlining these challenges. This review gives an 
account of some of the key challenges from self-management and health-care provider 
perspective. The recommendations in this review provide insights for building a more 
structured model for GDM care in India. This research has several practical applications. 
First, it points out to reaching a consensus on approaches for screening, diagnosis, 
and treatment of care across clinical practices in the nation that can aid in overcoming 
certain challenges observed. Second, it highlights the importance to build capacities and 
capabilities, especially in resource-limited settings. Health education among pregnant 
women remains a priority to resolve issues related to self-management. More broadly, 
further research, specifically qualitative is vital to determine forthcoming challenges with 
respect to patients, caregivers, providers, and policy makers and to provide solutions 
fitted to practice setting and demographic background.
Keywords: gestational diabetes mellitus, india, health care, challenges, recommendations, gestational diabetes 
mellitus management
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BACKGROUND
Gestational diabetes mellitus (GDM) affects a significant 
proportion of pregnant women worldwide. GDM occurs when 
a woman’s pancreatic function is not sufficient to overcome 
the diabetogenic environment of pregnancy and causes high 
blood glucose levels due to the body’s extra demand for insulin 
(1). A variety of factors like age, diet, obesity, ethnicity, family 
history, history of GDM in previous pregnancy, macrosomia, 
essential hypertension or pregnancy-related hypertension, his-
tory of spontaneous abortions, and unexplained stillbirths cause 
an increased risk of glucose intolerance in pregnant women 
(2, 3). Globally, the prevalence of GDM varies widely depending 
on the population studied and the diagnostic test employed by 
researchers. Research suggests that GDM occurs in 2–10% of all 
pregnancies depending on the populations studied (4). In 2013, 
hyperglycemia in pregnancy was evident in approximately 17% 
of all live births across the world (5). Women with GDM have a 
40–60% chance of developing diabetes mellitus over 5–10 years 
after pregnancy (6). Also, children born in GDM pregnancies face 
an increased risk for obesity and type 2 diabetes (7). Although 
GDM-associated mortality is rare, maternal and fetal mortality 
can occur when glucose levels are poorly controlled (8).
In India alone, GDM affects five million women each year (9). 
The Women in India with Gestational Diabetes Mellitus Strategy 
(WINGS) program, jointly conducted by the International 
Diabetes Federation (IDF), the Madras Diabetes Research 
Foundation, and the Abbott Fund, highlighted that prediabetes 
and diabetes affect approximately six million births in India 
alone, of which 90% are due to GDM (10). Hence, as per the 
WINGS study, only half of these women were tested postpartum 
for GDM, and there was no consensus among physicians as to 
when a woman should undergo oral glucose tolerance test after 
delivery despite available guidelines (10). This shows that the 
management of GDM is still challenging and controversial with 
conflicting guidelines and treatment protocols, despite availabil-
ity of straightforward protocols for screening and management 
in the general population (10, 11). Also, effective communication 
among physicians, patients, and primary care providers is essential 
for GDM management, as patient compliance and proper educa-
tional interventions promote better pregnancy outcomes (12, 13). 
The cornerstone for the management of GDM is glycemic control 
and quality nutritional intake. However, GDM patients who fail 
to control their glucose levels through lifestyle modifications may 
require insulin. The national list of essential medicines in India 
includes insulin, which is considered as the gold standard for gly-
cemic control during pregnancy (14). Therefore, it is affordable 
and easily accessible at the primary, secondary, and tertiary levels 
of health care in India. Nonetheless, there is no consensus on 
when to initiate insulin therapy for GDM in India (15). Research 
suggests that interventions such as self-management are effective 
in improving glycemic control, lowering health-care costs, and 
improving the quality of life in patients with diabetes (16, 17). 
However, the specific challenges in the effective self-management 
of GDM are not fully established, particularly among women 
with GDM in India, adding woes to already muddled provider 
management.
Existing studies show some of the challenges, knowledge 
gaps, and approach to GDM care. But, inefficiencies in establish-
ing these challenges contribute to suboptimal patient outcomes 
(10, 13). Therefore, to confront the impediments in GDM manage-
ment, it is also essential to understand the solutions that exist. The 
goal of this study was to review the available literature to establish 
the challenges and potential opportunities for improving GDM 
care in India and provide recommendations for the same.
MeTHODOLOGY
The literature review focused on identifying the existing gaps and 
challenges in GDM management in India. The researchers identi-
fied studies that evaluated challenges in self-management and 
provider management of GDM in India. The researchers collected 
data through an extensive literature review process to present the 
consolidated information. First, key search terms like “Gestational 
diabetes,” “Gestational diabetes mellitus,” “GDM,” “epidemiology,” 
“challenges,” “barriers,” “management,” “screening,” “diagnosis,” 
“treatment,” “patient education,” “patient-centered care,” “recom-
mendations,” “solutions,” and “India” were defined. Data were 
extracted using the search terms from diverse fields like health 
policies, obstetrics care, diabetes management, health-care access, 
health services research, and guidelines. The researchers then 
conducted iterative searches in electronic databases like Medline, 
PubMed, Cochrane Library, and references of selected articles 
to find relevant material on GDM in India. Since the subject 
demanded a thorough and systematic search, the data sources were 
not only limited to articles published in journals but also included 
gray literature. The sources for gray literature were as follows:
•	 Physician forums
•	 Institutional repositories like archives in hospital websites
•	 Physician association websites
•	 Popular Internet search engines
•	 Others (blogs, newsletters, and forums)
The search strategy was broad and sensitive to include as many 
relevant articles through subsequent manual screening. Again, 
the reference lists of relevant reviews and articles were thoroughly 
reviewed to ensure all important studies were covered. A thematic 
analysis approach was used to analyze the data retrieved in this 
review. The key challenges were segregated into categories that 
had similar ideas, concepts, or themes. The findings were then 
presented and discussed in detail.
ReSULTS
The researchers retrieved 87 articles from the initial search. 
Subsequently, the process of abstract sifting yielded 35 relevant 
articles that described GDM, its management, challenges, and 
other related information. The common reason for exclusion was 
non-relevance. Of these shortlisted articles, 25 citations met the 
inclusion criteria and were reviewed further (Figure 1).
Characteristics of the Studies included
We analyzed 25 studies for this review. Among the 25 studies on 
GDM, 6 (12, 13, 18–21) were on screening, 7 (10, 11, 13, 20, 22–24) 
FiGURe 1 | The process of article selection for review.
3
Morampudi et al. GDM Care: Challenges and Recommendations
Frontiers in Endocrinology | www.frontiersin.org March 2017 | Volume 8 | Article 56
on diagnosis, 9 (10, 11, 23, 25–30) on management, 8 (26–29, 
31–34) on awareness, and 5 (31, 35–38) on epidemiology. The 
increase in the total number of studies is due to the single studies 
that focused on more than one topic. Of the 25, 8 studies (12, 20, 
21, 25, 27, 28, 30, 32) were literature reviews/editorials, 13 (10, 13, 
19, 22, 26, 31, 35–38) epidemiological studies and surveys, and 4 
(11, 18, 23, 34) reports/practice guidelines. The characteristics of 
these studies are also listed in Table 1.
Overall, three studies furnished data on self-monitoring of 
glucose levels and regulation of diet and exercise, adherence 
to medications, and periodic follow-up with the health-care 
provider. Similarly, 12 studies discussed GDM awareness among 
patients, management guidelines (prepartum to postpartum), 
patient compliance, and the need for educational and behavioral 
counseling. The data from 13 studies highlighted GDM care in 
India and discussed cultural tailoring of interventions, inconsist-
encies in screening, diagnosis and management guidelines across 
practices, individualized assessment and reassessment, and use of 
treatment algorithms by various health-care providers.
Analysis
We analyzed data from these studies and categorized the chal-
lenges under two key themes covering the vital aspects of GDM 
care (Figure 2):
•	 Challenges in self-management
•	 Challenges in provider management
In addition, we provided recommendations for the outlined 
challenges based on relevant information extracted from these 
studies (Table 2).
DiSCUSSiON
Before expounding the challenges and recommendations to 
GDM care, it is necessary to acquaint with the health-care deliv-
ery system in India.
Overview of Health System in india
Health-care system in India is categorized into two major 
sectors: public and private (Figure  3). The public health-care 
system chiefly includes secondary and tertiary care institutions 
in key cities and primary health-care centers in rural areas (39). 
On the other hand, the private sector provides majority of care 
through secondary, tertiary, and quaternary institutions with a 
major focus in tier I and tier II cities (39). Thus, the health-care 
infrastructure in urban and rural India is not evenly distributed 
and not at proximity, mostly in case of rural areas. Although, 
health-care services in the public sector are offered free of charge 
to all citizens, people often end up with high out-of-pocket 
expenditures because they often prefer services from private 
health care due to quality of care (40). Further, the health-care 
costs vary within the private sector based on the facilities and 
care offered, leading to issues related to affordability. On the 
whole, the total expenditure for health in India was 4.7% of GDP 
in 2014 of which public and out-of-pocket health expenses were 
30 and 62.4%, respectively (41).
Apart from public and private health-care providers, non-
profit organizations and non-governmental organizations 
also play a pivotal role for GDM-related advocacy. Currently, 
organizations, both national and international, such as IDF, 
Bill and Melinda Gates Foundation, Jagran Pehel, Women and 
Children First, Public Health Foundation of India, and others 
work toward promoting maternal and child health (9, 42–45). 
Another coalition in India that strives toward the same goal is the 
reproductive, maternal, newborn, child, and adolescent health 
(RMNCH+A) coalition, which is led by Save the Children India 
under the support of the Government (46). The coalition includes 
central and state government agencies, academia, research and 
training institutes, health-care professional associations, local 
bodies (Panchayats and Nagarpalikas), non-governmental 
organizations, civil society organizations, faith-based organiza-
tions, media, corporate organizations, bilateral and multilateral 
donors, and United Nations agencies (46). RMNCH+A aims to 
work more effectively in collaboration with multiple stakehold-
ers to enhance joint action and accountability and to support the 
implementation of national commitments and policies (46). In 
2005, a global alliance “The Partnership for Maternal, Newborn 
& Child Health” of more than 700 organizations in 77 countries 
representing the sexual, reproductive, maternal, newborn, child, 
and adolescent health communities, as well as health influencing 
sectors, was established (47). This partnership provides a plat-
form for organizations in India to align objectives, strategies, and 
resources and to achieve consensus on interventions to improve 
maternal, newborn, child, and adolescent health (47).
TABLe 1 | Characteristics of studies included.
Author(s) Study objective(s) Study design Area of study
1 Mahalakshmi 
et al.
To obtain information on existing practices in the diagnosis and management of gestational 
diabetes mellitus (GDM) among physicians/diabetologists/endocrinologists and obstetricians/
gynecologists in India
Epidemiological study (online/
in–person surveys) (10)
Current practices 
in diagnosis and 
management
2 Seshiah et al. To outline Indian guidelines for diagnosis and management of GDM Practice guidelines (11) Diagnosis and 
management
3 Mohan et al. To assess the criteria to be used to diagnose GDM Review (12) Screening
4 Balaji et al. To elucidate a test that is casual and reliable to diagnose GDM Epidemiological study 
(prospective cohort study) (13)
Screening and 
diagnosis
5 Seshiah et al. To outline the necessity of screening for all Indian pregnant women Practice guidelines (18) Screening
6 Raja et al. To estimate the prevalence of GDM and various sociodemographic factors of the studied 
subjects
Epidemiological study 
(community-based cross 
sectional study) (35)
Epidemiology
7 Seshiah et al. Presents updated clinical evidence with expert inputs in the context of Indian clinical practice Editorial (25) Guidelines 
management
8 Jain et al. To study the effect of glucose levels on maternal and fetal outcomes Epidemiological study 
(prospective cohort study) (36)
Epidemiology
9 Seshiah et al. No data are available about the prevalence of glucose intolerance during pregnancy in our 
country, and hence a study was undertaken on this aspect
Epidemiological study 
(prospective study) (37)
Epidemiology
10 Arora et al. To determine the prevalence and risk factors of GDM comparing the previous World Health 
Organization (WHO) 1999 criteria to the WHO 2013 criteria in North India
Epidemiological study 
(cross-sectional design with a 
questionnaire) (38)
Epidemiology
11 Kayal et al. Women in India with Gestational Diabetes Mellitus Strategy (WINGS): methodology and 
development of model of care for GDM (WINGS 4)
Epidemiological study 
(situational analysis) (26)
Management 
and awareness
12 Jindal et al. To study the prevalence of glucose intolerance at 6 weeks postpartum in Indian women with 
GDM diagnosed according to ADA criteria
Epidemiological study 
(longitudinal study) (31)
Epidemiology 
and awareness
13 Mohan et al. The aim of this study was to compare the Diabetes in Pregnancy Study Group of India (DIPSI) 
criteria with the WHO 1999 and the International Association of the Diabetes and Pregnancy 
Study Groups (IADPSG) criteria for GDM
Epidemiological study 
(prospective study) (19)
Screening
14 Pulkit et al Our objective was to study the implications of implementing the IADPSG guidelines or DIPSI 
guidelines for screening and diagnosis of GDM in Indian population. Another objective was to 
evaluate the importance of isolated fasting glucose, which is the main difference between the 
two guidelines
Epidemiological study (retro-
prospective study) (22)
Diagnostic 
criteria
15 Madhab et al. To advocate policy change for GDM in India Review (32) Awareness
16 Mithal et al To understand the impact of GDM Editorial (27) Awareness and 
management
17 Poomalar To understand changing trends in management of GDM Review (28) Awareness and 
management
18 International 
Diabetes 
Federation
This project aimed to develop a context-adapted model approach to care in low-resource 
settings, which confronts the widespread challenges in GDM screening and management
Epidemiological study 
(situational analysis) (29)
Awareness and 
management
19 National Health 
Mission, 
Government of 
India
Guidance note on National Guidelines for Diagnosis & Management of GDM Practice guidelines (23) Diagnosis and 
management
20 Bhavadharini 
et al.
This review intends to provide an overview of the evolution of the screening and diagnostic 
criteria for GDM
Review (20) Screening and 
diagnostic 
criteria
21 Sharma et al. To elucidate an evidence-based single glucose challenge test to diagnose GDM Epidemiological study (cohort 
study) (24)
Diagnosis
22 Gupta and 
Kalra
To evaluate methods that improve postpartum screening rates Review (21) Screening
23 Kalra et al. To elucidate psychological effects of GDM on pregnant women Editorial (30) Management
24 Shriraam et al. Awareness of GDM among antenatal women in a primary health center in South India Epidemiological study (survey) 
(33)
Awareness
25 Jagran 
Prakashan 
Limited
Annual report (2010–2011) with all the initiatives that Jagran Pehel has embarked upon in the 
particular year
Report (34) Awareness
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FiGURe 2 | Challenges in GDM management.
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To establish the existing challenges and recommendations 
for GDM care in India, the study researchers performed a nar-
rative review using available literature on GDM in India. The key 
challenges identified during this review with regard to self-man-
agement and provider management included awareness, acces-
sibility, compliance issues, and cultural context of care. The study 
researchers discussed the identified challenges and suggested 
recommendations based on the findings from the literature. Also, 
the researchers have provided additional recommendations in 
context of the findings after reviewing the most recent guideline 
documents and several international publications to suggest the 
best practices for GDM management.
Challenges in Self-Management
Some major challenges in the self-management of GDM were 
social taboos, cultural habits, GDM awareness, adherence, lack of 
patient motivation, screening costs, and transportation to nearest 
centers. Many of these challenges do not require adequate resources, 
but simple policy changes to improve GDM awareness. In India, 
the growing concern of family and friends for a pregnant woman 
and her baby is a major factor. Almost everyone within the family 
has an opinion. This can confuse and complicate the pregnant 
woman’s decisions to follow the health-care professional’s advice. 
The lack of information in communities and sometimes cultural 
perspectives are barriers to GDM care. Myths like “exercise harms 
the baby” and “pregnant mothers must consume food for two” 
cause negative strongholds in pregnant women, preventing them 
from following the instructions of their health-care professionals 
to exercise and adhere to a certain diet. Some patients are even 
reluctant to ask questions, suggesting poor interaction with the 
health-care providers leading to misconceptions (48, 49). Hence, 
many women remain sedentary during pregnancy because of 
these perceived barriers. Many women crave certain food items 
during pregnancy, and the temptation for food that is not neces-
sarily nutritious, especially carbohydrates, is a major obstacle to 
adherence (48, 49). Although studies suggest that exercise is good 
in pregnant women, in reality, compliance to diet, exercise, and 
medications is a major challenge to care in GDM patients, given 
one’s cultural habits. There is a need to increase awareness among 
patients on the importance of diet, exercise, and medication while 
educating them on myths and health facts (48, 49).
The lack of awareness on GDM among patients is a major hur-
dle to its successful management. Majority of patients know little 
about blood glucose monitoring and adherence to treatment. This 
affects the treatment process and benefits. The limited knowledge 
on dietary issues and disease management causes malnutrition 
for both the mother and the fetus due to poor glucose control 
(49). Therefore, it is vital to educate patients about the disease, 
its complications, management strategies, and the importance 
of adherence. Previous research also suggests that information is 
crucial for patient adherence to treatment and self-management 
of the disease (48). However, the sources of information must be 
reliable. At all times, health-care providers are the greatest source 
of valid, reliable, and comprehensive information on GDM and 
its management.
Although pregnant women try to meet their nutritional 
needs and are careful about their own health, they disregard the 
importance of medicine. Studies show that GDM patients often 
encountered fear and emotional disturbances when informed 
about the consequences of the disease (48, 49). So, educating 
them on the importance of medicine and adhering to dietary 
recommendations improves their medicine intake and makes 
them more likely to embrace a healthier routine (49, 50).
Adding to the disease burden, the costs associated with GDM 
management are a barrier for pregnant women seeking consulta-
tion with the doctor and antenatal care. In India, many patients 
do not have health insurance and everything is out of pocket 
for major health services during pregnancy. Equipment such as 
glucometers and related supplies, medications, and diet modifica-
tions cause financial burdens. Low income, limited availability 
of public health centers at close proximity, and periodic travel 
to hospital for follow-ups also add to the financial burden of 
pregnant women in rural areas. Thus, there is a need to increase 
access to health-care services to reduce GDM burden in India.
Challenges in Provider Management
Some of the major challenges encountered in provider manage-
ment were getting pregnant women to visit in a fasting state, getting 
blood samples, lack of trained phlebotomists, and standardized 
laboratories for blood glucose estimations, conflicting guidelines 
across practices and patient compliance (12). Screening should be 
made mandatory for all pregnant women due to the high preva-
lence of GDM among Indian women. The GDM status should be 
a part of a physician’s routine history assessment, irrespective of 
the pregnancy or parity, as GDM is a precursor for type 2 diabetes 
(51). Therefore, early screening and diagnosis can prevent obesity, 
TABLe 2 | GDM management: challenges and recommendations.
Themes Sub-themes Challenges and recommendations
Challenges in 
self-management
Awareness Disease: one key challenge in India was inadequate awareness about the disease among the public. Hence, creating gestational 
diabetes mellitus (GDM) awareness among public is an imperative
Recommendations: increased knowledge about GDM among antenatal women pave way to a healthy lifestyle, better health-
care-seeking pattern and self-care and thus prevention and early diagnosis of the disease (33). Television/radio, neighbors/
friends, and family members seemed to be preferred sources of GDM awareness compared to doctors, health-care workers, 
or hospital charts/boards from which lesser proportion of women sought information from Ref. (33). However, this was the 
rural scenario. Many researchers opined that mass media should be properly utilized to increase service utilization for GDM by 
showcasing evidence, raising awareness, and creating public opinion through dialog and discussion. Several programs were 
implemented to increase awareness about GDM among pregnant women in India (27). One such campaign was Jagran Pehel 
(a social initiative by Jagran Prakashan Limited), which was supported by the World Diabetes Foundation. The program reached 
over half a million people in seven districts of four states in northern India. Information on GDM was exchanged with over 3.7 
million people using the mass media. Health-care workers have to play a greater role in creating awareness on GDM among 
antenatal women (34)
Management: many women are unaware of the importance of GDM management. Upon diagnosis with GDM, doctors advise 
either lifestyle or medical interventions. Self-management is also vital. GDM patients are closely monitored until delivery and even 
beyond. However, such interventions are not recognized by many patients, especially in the rural sector. A study conducted among 
primary health centers showed that women were well aware of the importance of diet and exercise in GDM and the probability 
of untreated GDM posing a risk to the unborn child. However, knowledge about the risk factors and course of GDM and that the 
women diagnosed with GDM are at an increased risk for future type 2 diabetes was low (33). Insufficient information on maintaining 
blood glucose within the recommended range is a risk factor in GDM. Also, lack of awareness about GDM and its complications, 
late contact with the health-care provider, costs involved in treatment, and the myths surrounding insulin use are some serious 
threats to GDM care (26). Many women with GDM experience pregnancy-related complications including high blood pressure, 
large birth weight babies, and obstructed labor (29). Globally, data show that children of mothers with uncontrolled diabetes—
either pre-existing or originating during pregnancy—are four to eight times more likely to develop diabetes in later life compared to 
their siblings born in a non-GDM pregnancy (27, 31)
Recommendations: knowledge about the risk factors and the consequences of untreated GDM are highly important for women 
to take proper precautions and self-care (33). As GDM is associated with adverse fetal, neonatal, and long-term complications, 
there is a need to improve awareness among women for preventing and managing GDM (28). Lifestyle interventions or metformin 
are offered to women with GDM. Patients must be aware of the importance of self-management and be educated about the same. 
Information guides and charts on food, exercise, and usage of glucose monitors aid in self-management (26, 28)
Social taboos and myths: there are social taboos and myths in Indian communities that interfere with the effective management 
of GDM. Particularly, in rural areas, a diagnosis of GDM can enhance stress in pregnant women due to misconceptions among 
family members leading to conflicts. Further, given the high unawareness about GDM, the in-laws of the woman may accuse her 
off keeping the ailment a secret from before marriage. Other accusations can be that the GDM is the patient’s fault, because of 
eating too much or not performing domestic chores (30). Many false perceptions interrupt the doctors’ recommended lifestyle 
interventions such as a pregnant women should give into her cravings for sweets if she will listen to the doctor and exercise can 
harm the baby. This can have a deleterious effect on the patient’s health and the fetus. Also, a lack of awareness about the myths 
surrounding insulin use also poses a serious threat to GDM care (26)
Recommendations: many studies suggest the need to educate pregnant women on issues related to GDM like the importance 
of regular monitoring, follow-up, information from the right sources, reliance on health-care providers, and more (26, 33). Lifestyle 
modifications like increase in physical activity, decrease in consumption of sweetened beverages, and high-energy dense food item 
should be introduced earlier and continued throughout the life as advised by health-care providers
Accessibility Management: health-care resources are insufficient. This results in a large population being hesitant to access health care for 
diseases with not so “obvious” implications like GDM (12). There are several challenges in the screening and diagnosis for GDM 
in India. Some of the major patient-related barriers are late contact with the health-care system as pregnant women have to travel 
long distances to meet the doctor, women not routinely attending antenatal check-up in a fasting state, and lack of awareness 
about GDM and its complications. Hence, making women undergo the test in the fasting state could be a challenge (12, 20)
Recommendations: direct home visits, screening with hemoglobin A1C levels and self-administered oral glucose tolerance test 
may lead to increased testing rates and may be a part of the solution of this complex problem (21). The need to train manpower 
and mobilize resources to improve access also is recommended (27)
Cost to care Cost to care: costs of care may be a concern for patients, especially from the rural sectors
Recommendations: studies suggest the need for a cost-effective, evidence-based and patient-friendly approach to the diagnosis 
and management of GDM (24). The best strategies for screening and diagnosis should be based on the cost and availability of the 
local health facilities (20). Many women with GDM also develop type 2 diabetes, resulting in further health-care complications and 
costs (29). The DIPSI criterion is a one-step cost-effective and evidence-based procedure to diagnose GDM in any socioeconomic 
setting (12, 13, 23). The Indian Ministry of Health introduced free screening for GDM among the five services offered to pregnant 
women below the poverty line in the National Rural Health Mission program. Several state governments like Bihar, Delhi, 
Jharkhand, and Punjab have pledged similar initiatives for GDM; the Government of Tamil Nadu is already implementing such a 
policy (32)
(Continued )
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Themes Sub-themes Challenges and recommendations
Challenges 
in provider 
management
Awareness Guidelines and criteria: screening, diagnosis, and treatment: the lack of trained health-care professionals and phlebotomists, 
scarcity of diagnostic facilities and standardized laboratories, storage and transport of blood samples, etc. are a few barriers to 
screening and diagnosis in low-resource settings (20). Also, there is inconsistency in the guidelines followed by doctors across 
the nation. Women with a history of GDM are greatly at a risk of subsequent diabetes and should be screened for prediabetes or 
diabetes. Health-care providers need to be aware of this
Recommendations: the need to train manpower and mobilize resources to improve access is recommended (27). Universal 
screening for GDM should be followed, as women of Asian origin, especially Indians, are at a higher risk to develop GDM and 
subsequent type 2 diabetes (35). Blood sugar levels can indicate maternal and perinatal morbidity and mortality in GDM cases. 
Therefore, there is a need for unified diagnostic criteria and guidelines to create awareness among all Indian laboratories (19, 
22, 23, 36, 38). DIPSI recommends a 75 g oral glucose load and a venous blood sample after 2 h to estimate plasma glucose 
for a pregnant woman visiting an antenatal clinic in the fasting state. Screening is recommended between 24 and 28 weeks of 
gestation. A team approach is ideal for managing women with GDM (18, 25). The maternal health and fetal outcome depends 
upon the care by the committed team of diabetologists, obstetricians, and neonatologists; also, health-care providers need to have 
a collaborative approach (18, 25). A short-term intensive care gives a long-term pay off in the primary prevention of obesity, IGT, 
and diabetes in the offspring, as the preventive medicine starts before birth (18)
Compliance Patient compliance: a major challenge for doctors is that patients do not comply with the treatment or the recommended 
number of follow-up visits due to various reasons
Recommendations: general awareness about GDM and risk factors, diagnosis, treatment, and consequences of GDM may 
improve treatment compliance and self-management in patients (33). The increasing prevalence of GDM and its comorbidities 
among pregnant women demands the need to educate patients on compliance (34)
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impaired glucose tolerance, and diabetes in the progenies and 
mothers (52).
Most researchers shared the same opinion that GDM 
screening is widely deliberated, more specifically on selective 
versus universal screening, timing of testing, methods, and the 
diagnostic criteria. Some of the controversies surrounding this 
subject remain unresolved (53). First, getting a pregnant woman 
to undergo a GDM screening in a fasting state is challenging, par-
ticularly in a country like India. Second, multiple screening tests 
to diagnose GDM coupled with factors such as low awareness, 
less accessibility, and low affordability are a concern in resource-
limited settings. Therefore, the World Health Organization 1999 
criteria, which require only a single sample in comparison to the 
three samples required by the International Association of the 
Diabetes and Pregnancy Study Groups (IADPSG) criteria and 
four samples required by the Carpenter and Coustan criteria, 
became very popular in India initially (54). In 2014, the Ministry 
of Health and Family Welfare had developed technical and opera-
tional guidelines for identification and management of GDM in 
India. The national guidelines for diagnosis and management of 
GDM recommend a single-step procedure using 75 g oral glucose 
in a fasting or a non-fasting state and measuring plasma glucose 
2 h postingestion (23). This one-step procedure to diagnose GDM 
is preferred as it is simple, economical, and feasible. Although the 
criteria for screening and diagnosis are established, uncertainty 
still exists on the execution methods.
Screening remains vital to prevent GDM-related complica-
tions during perinatal period and delivery. Evidence suggests 
that universal screening improves pregnancy outcomes com-
pared to selective screening (55). Many guidelines recommend 
universal screening, while others exempt patients categorized 
as low-risk groups. Low-risk patients are younger than 25 years, 
have normal body weight, have no first-degree relatives with 
diabetes, show no history of abnormal glucose metabolism or 
poor obstetric outcomes, and are not from an ethnic group with a 
high diabetes prevalence (Hispanic American, Native American, 
Asian American, African American, and Pacific Islander) (56). 
Contrarily, a few researchers argue that selective screening based 
on the clinical characteristics of a pregnant woman facilitates 
efficient screening for GDM (57). The risk for GDM varies 
among different pregnant women based on marked obesity, pre-
vious history of GDM, glycosuria, or family history of diabetes. 
Nonetheless, all pregnant women should be screened for GDM 
during their first antenatal visit (51). Although few experts object 
to the screening of low-risk patients routinely, research suggests 
that non-screening omits approximately 4% patients with GDM 
(58). Universal screening for GDM detects more cases and 
improves maternal and neonatal prognosis compared to selective 
screening (59). The US Preventive Services Task Force (2014) also 
recommends that all asymptomatic pregnant women be screened 
for GDM after 24 weeks of gestation (53).
Many International medical associations like the American 
College of Obstetricians and Gynecologists, the American 
Endocrinology Society, the Canadian Diabetes Association, 
Australian Diabetes Association, and the Diabetes in Pregnancy 
Study Group of India also endorse that screening for GDM 
should be universal. Although certain organizations like the 
American Diabetes Association (ADA) and the National Institute 
for Health and Care Excellence recommend selective screening, 
even they agree that Asians, especially Indians, are a high-risk 
ethnic group (12). Therefore, Indian pregnant women should 
be universally screened at their first registration. The benefits of 
universal screening cannot be ignored in the long term given the 
high prevalence of GDM across India in spite of the increased 
screening costs for the government and individuals (51, 59).
Gestational diabetes mellitus patients ideally need counseling 
about the disease from the time of diagnosis. The education 
should cover recommended diet, exercise, treatment, self-care, 
and monitoring. There is also a need to train them efficiently to use 
monitoring equipment for self-management. The patients’ family 
TABLe 2 | Continued
FiGURe 3 | An overview of indian healthcare system.
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members should also be educated on emotional and psychological 
support, the needs associated with GDM, and general pregnancy 
care. It is vital to highlight the importance of antenatal care and 
that GDM management requires a holistic support system. The 
first line of management for women with GDM is medical nutri-
tion therapy (MNT) or dietary modification, followed by physical 
activity and monitoring of blood glucose levels. MNT reduces 
pregnancy and perinatal complications and brings glycemic con-
trol (8). A study by Jovanovic-Peterson et al. showed that exercise 
(arm ergometer training) coupled with dietary modifications 
improved glycemic control compared to dietary modifications 
alone (60). Home-based exercise training improved capillary 
glucose profile in women with gestational diabetes. A study 
by Halse et  al. showed that home-based cycling is effective in 
maintaining daily postprandial normal glycemic levels in women 
with diet-controlled GDM. Further, the researchers noticed that 
the compliance to the supervised exercise training was good, 
and capillary glucose concentration reduced in response to each 
cycling session despite high consumption of dietary carbohy-
drates (61). Exercise proved to be beneficial in GDM patients, 
but there are no guidelines for the same until recently. In 2015, 
Padayachee and Coombes drafted the first guidelines on exercise 
for GDM management (62).
Further, in women prescribed with insulin, hospitalization 
proved to be effective in achieving treatment compliance to regu-
late glucose levels (48). Although it is not possible to hospitalize 
every GDM women to regulate glucose levels in resource-limited 
settings, it can be inferred that managing GDM requires a col-
laborative approach. Well-trained professionals play a crucial role 
in screening, diagnosis, and treatment. A team approach is ideal 
to manage women with GDM usually comprising an obstetri-
cian, diabetologist/endocrinologist, health education provider, 
dietitian, and neonatologists/pediatrician (18).
Intensive monitoring, diet, and insulin are the cornerstones of 
GDM management. Until there is absolute evidence that ignoring 
maternal hyperglycemia is acceptable when the fetal growth pat-
terns appear normal on the ultrasonogram, it is prudent to achieve 
and maintain normal glycemic levels in every pregnancy compli-
cated by GDM. The maternal health and fetal outcome depend 
on the care by a committed team of health-care professionals. A 
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short-term intensive care gives long-term benefits in preventing 
obesity, impaired glucose tolerance and diabetes in the offspring, 
as the preventive medicine starts before birth. The future solutions 
offered by physicians should focus on tangible and simple ways 
to better monitor patients and standardize care across practice.
CONCLUSiON
In India, GDM management is complex, and existing challenges 
are multifactorial. This review established some of the key chal-
lenges from self-management and health-care provider perspec-
tive. The recommendations provided in the literature and by this 
study researchers pave way for building a more structured model 
for GDM care in India. Reaching a consensus on approaches 
for screening, diagnosis, and treatment of care across clinical 
practices in the nation can aid in overcoming certain challenges 
observed. It is important to build capacities and capabilities, 
especially in resource-limited settings. Health education among 
pregnant women remains a priority to resolve issues related to self-
management. To conclude, periodic research, specifically qualita-
tive, can elicit forthcoming challenges with respect to patients, 
caregivers, providers, and policy makers and provide solutions 
tailored to practice setting and demographic background.
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